Planning to go to Kyrgyzstan for IVF?We suggest getting these three tests done before you set off.

When you decide to begin your IVF-assisted conception journey in Kyrgyzstan, there is one thing more urgent than booking flights before you leave—get your baseline tests done thoroughly in your home country first. The purpose of these tests is not to “prove whether you can do it,” but to give overseas doctors a preliminary understanding of your ovarian reserve and overall baseline condition before they have even met you in person, so they can plan the follow-up itinerary more specifically.

I. AMH: The “Inventory Indicator” of Ovarian Reserve

AMH (anti-Müllerian hormone) is one of the important indicators currently used to assess ovarian reserve function. It reflects the approximate number of remaining follicles in the ovaries and helps you determine whether you fall into the “relatively good reserve,” “normal,” or “low” range. But two points need to be made clear: low AMH ≠ no eggs; it only tells the doctor that the “inventory is low” and a more refined protocol is needed. High AMH ≠ guaranteed easy pregnancy; it only reflects “quantity,” not “quality.” When you see that your result is high or low, there is no need to be overly anxious—it is only one reference dimension. Doctors in Kyrgyzstan will give a comprehensive assessment and recommendations based on your overall situation. AMH values are relatively stable and are not affected by the menstrual cycle, so blood tests can be done at any time. If you have had the test within the past 3 months, please keep the report so the doctor can observe the trend of changes.

II. Six-Hormone Panel: A Window into Your “Current Status”

The six-hormone panel usually includes: FSH, LH, E2, PRL, P, and T. Before seeking medical care abroad, the key focus is on FSH, LH, and E2 on days 2–4 of menstruation. The significance of these three indicators:

(1) FSH (follicle-stimulating hormone): reflects the ovaries’ potential response to ovulation induction drugs. A higher value suggests that the ovaries’ response to stimulation may be weaker.

(2) LH (luteinizing hormone): works together with FSH in follicular development and ovulation.

(3) E2 (estradiol): assesses the baseline estrogen level; if too high, it may suppress FSH and affect protocol design.

For timing, it is recommended to have the blood draw on days 2–4 of the menstrual cycle, because data from this period best reflects the “baseline state.” On the report, please mark the blood draw date and which day of the menstrual cycle it is, for easier reference and comparison.

III. Transvaginal Ultrasound: Visually “Counting” Follicle Reserve

Transvaginal ultrasound is mainly used to count antral follicles (AFC) and observe the uterine environment. It is performed on days 2–4 of early menstruation. Through ultrasound, the doctor can see the number of small follicles in the ovaries, while also assessing endometrial thickness, echo homogeneity, and screening for obvious fibroids or polyps, etc. This information helps doctors determine the implantation window and protocol selection. It is recommended to have the examination on days 2–4 of menstruation. Keep the ultrasound images plus written descriptions, and organize multiple reports in chronological order so doctors can compare and observe changes.

AMH, the six-hormone panel, and transvaginal ultrasound—once these three baseline test reports are organized and sent to the doctor, they can help the doctor gain a clear understanding of your baseline situation even during the remote stage. However, the specific protocol still needs to be finalized by a reproductive doctor in Kyrgyzstan after an in-person consultation and follow-up results. Going to Kyrgyzstan for IVF-assisted conception involves multiple complex factors, including legal, medical, and psychological ones. Preparing these three baseline records in advance is not meant to “scare yourself,” but to help the doctor understand you faster and allow you to plan your trip more calmly.